Mallinckrodt Advocates For Comprehensive, Multi-Prong Action Plan To Fight Opioid Abuse And Misuse In The United States Post author:Sam Post published:September 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Rejects Johnson & Johnson's RA Drug Sirukumab, More Safety Data Needed September 24, 2017 McKesson Reports Fiscal 2017 Fourth-Quarter And Full-Year Results May 18, 2017 AstraZeneca Plots Crucial IDO Phase III Combo Trial With Incyte October 30, 2017